Global Cancer Diagnostics Device Market 2016-2020

Global Cancer Diagnostics Device Market 2016-2020

  • June 2016 •
  • 67 pages •
  • Report ID: 3938240 •
  • Format: PDF
About the Cancer Diagnostic Devices Market

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.
The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.
Technavio’s analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:
- Americas

Technavio's report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Abbott Diagnostics
- Agilent Technologies
- BD
- bioMérieux
- Qiagen
- Roche Diagnostics

Other prominent vendors
- Affymetrix
- Ambry Genetics
- Annoroad
- Aviva Biosciences
- Biochain
- Bio-Rad
- Cancer Genetics
- Cepheid
- CompanionDx
- DiagnoCure
- Epic Sciences
- Epigenomics
- Genomic Health
- HalioDX
- Hologic
- Illumina
- Myriad Genetics
- Thermo Fisher Scientific
- Ventana Medical Systems
- Vysis

Market driver
- Demand for personalized medicines
- For a full, detailed list, view our report

Market challenge
- High cost of developing companion diagnostics
- For a full, detailed list, view our report

Market trend
- Demand for personalized medicines
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


We are very sorry, but an error occurred.
Please contact if the problem remains.